Elizabeth Romano MSc DipM MCIM - Director of Communications and Participant Engagement

Elizabeth Romano is the Director of Communications and Participant Engagement at Richmond Pharmacology, where she plays a pivotal role in steering the company's communication and marketing strategies. Elizabeth leads a dynamic team dedicated to enhancing Richmond's brand image and driving key marketing initiatives.

In this strategic role, Elizabeth oversees all communication efforts, ensuring that Richmond's messaging is clear, consistent, and engaging across all channels. Her leadership is instrumental in fostering a collaborative and productive environment, guiding the marketing and participant engagement teams towards achieving their goals.

Elizabeth oversees the recruitment and retention of participants for clinical studies. This involves directing efforts to build a robust community of volunteers and patients, crucial for the success and feasibility of Richmond's trials.

Elizabeth's extensive marketing background, spanning over 20 years across various industries, equips her with the expertise needed to drive success at Richmond. Her innovative approach and commitment to excellence ensure that Richmond remains at the forefront of clinical trial excellence.

Connect with Liz on LinkedIn https://www.linkedin.com/in/lizromano/ 

Back to experts

Latest news

Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read more

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Events

JSCPT 2025

5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event